Figure 2From: Biomarkers of fatigue related to adjuvant chemotherapy for breast cancer: evaluation of plasma and lymphocyte expression Evaluation of plasma analytes in patients in the inclusion phase whose fatigue worsened and in patients whose fatigue did not worsen after the first cycle of chemotherapy (controls). The black dots represent the outliers.Back to article page